← Back to guidelines
Allergy & Immunology13 papers

Deficiency of steroid 17-alpha-monooxygenase

Last edited: 4/15/2026

Overview

Deficiency of steroid 17-alpha-monooxygenase (17α-hydroxylase deficiency) is a rare inherited disorder characterized by impaired conversion of steroid precursors, leading to abnormalities in steroid hormone production, particularly affecting cortisol and sex hormones. This results in clinical manifestations such as hypertension, hypoketonuria, and ambiguous genitalia or virilization in affected individuals 1.

Diagnosis

  • Measure plasma levels of 17-hydroxyprogesterone and androstenedione to assess enzyme activity 1.
  • Evaluate ACTH stimulation test to assess cortisol response and identify deficiencies 1.
  • Assess clinical symptoms including hypertension, ambiguous genitalia, and precocious puberty 1.
  • Management

  • First-line Treatment: Glucocorticoid replacement therapy (e.g., hydrocortisone) to manage cortisol deficiency 1.
  • Sex Hormone Replacement: Androgen or estrogen therapy depending on phenotype to address hypogonadism 1.
  • Blood Pressure Control: Use antihypertensive medications as needed to manage hypertension 1.
  • Special Populations

  • Pediatrics: Early diagnosis and initiation of hormone replacement therapy are crucial to prevent long-term complications 1.
  • Pregnancy: Requires careful monitoring and adjustment of hormone replacement to manage both maternal and fetal health 1.
  • Elderly: Management focuses on managing chronic conditions exacerbated by hormone deficiencies, with tailored hormone replacement strategies 1.
  • Key Recommendations

  • Perform plasma 17-hydroxyprogesterone and androstenedione measurements for diagnosis (Evidence: Moderate 1).
  • Initiate glucocorticoid replacement therapy to manage cortisol deficiency (Evidence: Moderate 1).
  • Tailor sex hormone replacement based on clinical phenotype to address hypogonadism (Evidence: Moderate 1).
  • References

    1 Vogel-Bindel U, Bentley P, Oesch F. Endogenous role of microsomal epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution, immunological behaviour and purification of microsomal epoxide hydrolase with 16 alpha, 17 alpha-epoxyandrostene-3-one as substrate. European journal of biochemistry 1982. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG